Deficiency of the dectin-1 receptor completely abrogated WGP-mediated anti-tumor effects (Qi et al., 2011) and it is not surprising that the antitumor immune effect of DCs was eliminated in the tumor and inflammatory microenvironment of dectin-1−/− mice. Here, CLEC7A is linked to neoplasm.